Skip to main content
search

Advancing Precision Medicine for Lung Cancer

                       

About the APOLLO Study

The Advanced Precision Observational Lung Living Outcomes (APOLLO) study was a pioneering initiative in lung cancer research, designed to advance precision medicine. This innovative study focused on collecting extensive data on the molecular and clinical characteristics of lung cancer patients to help optimize treatment outcomes.

Hightower Clinical’s approach emphasized the inclusion of smokers in the study, acknowledging the critical role smoking plays in lung cancer development and progression. By analyzing diverse patient profiles, including smokers, the study uncovered valuable insights into lung cancer biology and contributed to the development of personalized treatment strategies for individuals battling lung cancer.

Current Status

Not Recruiting

Study Count

01

Study Information

APOLLO – Lung Cancer (Bio repository)

Study NameProtocol NumberSponsor
APOLLO – Lung Cancer (Bio repository)

P-030101

PrognomIQ

Frequently Asked Questions

What happens if my condition worsens during the study?

If your condition worsens, the study team will work with your healthcare providers to ensure appropriate medical care. Your safety and well-being are the top priority, and you can withdraw from the study at any time if needed.

Is genetic testing involved in the APOLLO study?

Yes, the APOLLO study may include genetic testing as part of its efforts to understand molecular and clinical characteristics of lung cancer. The study team will explain the process and obtain your consent before conducting any genetic tests.

How is my privacy protected during the study?

The APOLLO study adheres to strict confidentiality protocols to protect your personal and medical information. Data is typically anonymized and used only for research purposes. The study team will provide details about data privacy during the informed consent process.

Close Menu